Dextrose and Electrolyte No. 48 is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Dextrose Monohydrate; Sodium Lactate; Potassium Chloride; Magnesium Chloride; Potassium Phosphate, Monobasic; Sodium Chloride.
| Product ID | 0338-0143_66433fbc-a5fb-470e-8a1f-2265b51b7231 |
| NDC | 0338-0143 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dextrose and Electrolyte No. 48 |
| Generic Name | Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride And Dextrose Monohydrate |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1979-02-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017484 |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | DEXTROSE MONOHYDRATE; SODIUM LACTATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE |
| Active Ingredient Strength | 5 g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |